All Episodes
5th World Sepsis Congress: Sepsis Research and Innovations — 122 episodes
121: 5th WSC – Prevention and Rehabilitation of Long-Term Sequelae From Sepsis
120: 5th WSC – Sepsis in Emergencies and Humanitarian Crisis
119: 5th WSC – State of the Art in Sepsis Research: Emerging Immunomodulatory Approaches
118: 5th WSC – Pediatric Sepsis: The LMICs Cannot Wait for Improved Outcomes Any Longer
117: 5th WSC – The Research Agenda for AMR and Sepsis
116: 5th WSC – AI Solutions for Sepsis
115: 5th WSC – Reducing Sepsis Mortality Through System Change – Lessons from Trailblazing Countries
114: 5th WSC – Infection Prevention and Control in Community and Healthcare Settings
113: 5th WSC – Bridging Sepsis Knowledge Gaps in HICs and LMICs
112: 5th WSC – Pathways for Sepsis Care – Integrated Emergency, Critical, and Operative Care (ECO)
111: 5th WSC – The Immunization Agenda for Sepsis
110: 5th WSC – Novel Approaches to Pathogen Detection and Sepsis Diagnostics
109: 5th WSC – The Voices of Patients in Advocacy, Research, and Beyond
108: 5th WSC – Sepsis Epidemiology and Clinical Data
107: 5th WSC – Opening Session
106: 5th WSC – Reminder
105: 5th WSC – Announcement
104: 2024 WSC Spotlight: Challenges and Solutions for Early Recognition and Treatment of Sepsis
103: 2024 WSC Spotlight: Personalized Approaches to Sepsis Management
102: 2024 WSC Spotlight – Closing the Needs in Pediatric Sepsis
101: 2024 WSC Spotlight – Detecting Sepsis in the Ventilated Patient
100: 2024 WSC Spotlight – The Role of Biomarkers in the Early Detection of Sepsis
99: 2024 WSC Spotlight – How Does Hypervolemia Increase the Mortality Risk in Sepsis?
98: 2024 WSC Spotlight – Data, AI, and Predictive Modeling in Sepsis
97: 2024 WSC Spotlight – The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients
96: 2024 WSC Spotlight – Opening Session – The Renewed Global Agenda for Sepsis
95: 2024 WSC Spotlight: Reminder
94: 2024 WSC Spotlight: Announcement
93: 4th WSC – An Update on Research on Sepsis
92: 4th WSC – Harnessing the Media to Advance the Global Fight Against Sepsis
91: 4th WSC – Maternal Sepsis: Why Is It Still in the Top 3 for Global Incidence of Sepsis?
90: 4th WSC – The Impact of Survivors and Family Members to Improve Sepsis Awareness and Advocacy
89: 4th WSC – Neonatal Sepsis Platforms and Guidelines
88: 4th WSC – Understanding and Improving Long-term Outcomes After Sepsis and COVID-19
87: 4th WSC – Lessons from the Pandemic to Fight Common Infections and Sepsis
86: 4th WSC – Biomarkers and Antimicrobial Stewardship – The Synergies to Diagnose Sepsis and to Prevent AMR
85: 4th WSC – The Potential and Challenges to Intervene with the Immune Response
84: 4th WSC – The Benefits of Multidisciplinary Teams in Sepsis Care on the Health Care Facility Level
83: 4th WSC – Advances in Timely Pathogen and Sepsis Detection
82: 4th WSC – Advances and Challenges by Our Regional Sepsis Alliances
81: 4th WSC – The Quality of Healthcare Systems and QI Efforts on Outcomes from Sepsis and Pandemics
80: 4th WSC – Overcoming Silos to Address Infection-Related Global Health Threats
79: 4th WSC – The Health Economic and Human Burden of Infections and Pandemics
78: 4th WSC – Opening Session – Key Success Factors to Address Global Health Threats
77: 4th WSC – Reminder
76: 4th WSC – Announcement
75: 2022 WSC Spotlight – Innovations in Quality Improvement Strategies in All Settings
74: 2022 WSC Spotlight – Pro-Con: Are Personalized Interventions in Sepsis Even Possible?
73: 2022 WSC Spotlight – Update on Adjunctive Sepsis and COVID-19 Therapies
72: 2022 WSC Spotlight – Antibiotics and Antivirals – How to Improve Efficacy and Minimize Harm
71: 2022 WSC Spotlight – How to Make the Most of Existing and Frugal Technologies
70: 2022 WSC Spotlight – Panel: Knowledge from COVID-19 to Improve Sepsis Care and Vice Versa
69: 2022 WSC Spotlight – Biomarkers in the Diagnosis and Management of Sepsis and COVID-19
68: 2022 WSC Spotlight – Could Enhanced Pathogen Diagnostics Change Sepsis Management?
67: 2022 WSC Spotlight – Reminder
66: 2022 WSC Spotlight – Announcement
65: WSC 2021 – Global Standards and Guidelines for the Management of Sepsis and COVID-19 Patients
64: WSC 2021 – Immunomodulatory Treatments in Sepsis and Severe COVID-19
63: WSC 2021 – Novel Approaches in the Diagnosis of Sepsis and COVID-19
62: WSC 2021 – Advances in Pathogen Detection and the Fight Against AMR
61: WSC 2021 – Impactful Trials and Innovative Trial Design in Sepsis and COVID-19
60: WSC 2021 – The Role of AI, Big Data, and Digitalization in Combating Sepsis and COVID-19
59: WSC 2021 – The Missing Stories Families and Survivors of Sepsis and COVID-19
58: WSC 2021 – Long-Term Sequelae from Sepsis and COVID-19
57: WSC 2021 – Understanding the Different Faces of Sepsis
56: WSC 2021 – The Voice of Healthcare Workers
55: WSC 2021 – Standards and Novel Approaches to Prevent Sepsis
54: WSC 2021 – A World Imbalanced: Sepsis and Inequity
53: WSC 2021 – Lessons Learned for Ending This and Preventing the Next Pandemic
52: WSC 2021 – Combating Sepsis Is a Great Patient Safety Strategy
51: WSC 2021 – The Impact of Policy, Healthcare, Science, and Public Private Partnership
50: World Sepsis Congress 2021 – Announcement
49: 2020 WSC Spotlight: Early Identification and Appropriate Clinical Management of Sepsis Saves Lives and Prevents AMR
48: 2020 WSC Spotlight – A Comprehensive and Integrated Approach to Preventing Sepsis and AMR
47: 2020 WSC Spotlight - Sepsis, Ebola, and COVID-19
46: 2020 WSC Spotlight - Antimicrobial Resistance: An Emerging Global Health Threat
45: 2020 WSC Spotlight - The Epidemiology and Burden of Sepsis
44: 2020 WSC Spotlight - Opening Session
43: 2020 WSC Spotlight - Announcement
42: 2nd WSC – The Most Important Sepsis Research in 2017/2018
41: 2nd WSC – Enhancing Recovery from Sepsis
40: 2nd WSC - Improving Awareness: National and Global Strategies
39: 2nd WSC – Sepsis Is a Devastating Disease: Listen to the Survivors and Those Bereaved
38: 2nd WSC – Challenges of Maternal and Neonatal Sepsis
37: 2nd WSC – Challenges of Sepsis Management in Children Around the Globe
36: 2nd WSC – Prevention of Infection and Sepsis
35: 2nd WSC – Update on Adjunctive Sepsis Therapies
34: 2nd WSC – Evidence Based Treatment of Sepsis II
33: 2nd WSC – Evidence Based Treatment of Sepsis I
32: 2nd WSC – Antimicrobial Therapy and Source Control II
31: 2nd WSC – Importance of Pathogen Detection and Sepsis Markers
30: 2nd WSC - Improving Early Detection and Quality of Care
29: 2nd WSC: Epidemiology of Sepsis
28: 2nd WSC: The Different Faces and Challenges of Sepsis
27: 2nd WSC: Antimicrobial Therapy and Source Control I
26: 2nd WSC: Sepsis - Still a Global Health Threat
25: Reminder: 2nd World Sepsis Congress on Sep 5th and 6th, 2018
24: Announcement: 2nd World Sepsis Congress
23: WSC Spotlight: Updates on Sepsis
22: WSC Spotlight: Neonatal Sepsis
21: WSC Spotlight: Maternal Sepsis
20: WSC Spotlight: Sepsis - The Challenges of Medicine, Politics, and Society
19: Reminder: WSC Spotlight on Sep 12th, 2017
18: Announcement: WSC Spotlight
17: WSC - Sepsis - A Global Health Threat
16: WSC - Novel Adjunctive Sepsis Therapies in Clinical Trials
15: WSC - Patient Safety and Quality Improvement II
14: WSC - Prevention and Treatment of ICU Related Posttraumatic Stress Disorders (PTSD) by Ann Parker
13: WSC - Challenges in the Management of Pandemics
12: WSC - Patient Safety and Quality Improvement III
11: WSC - Sepsis Kills: Early Intervention Saves Lives by Harvey Lander
10: WSC - Pathogen Detection and Sepsis Markers II
9: WSC - A Health Care Provider‘s Success to Reduce Sepsis Deaths - Martin Doerfler
8: WSC - Pathogen Detection and Sepsis Markers I
7: WSC - Lessons Learned from the 1918 Spanish Influenza - David Morens
6: WSC - The Challenges of Sepsis Management in Low and Middle Income Settings
5: WSC - Patient Safety and Quality Improvement I
4: WSC - The Challenges of Patients and Families
3: WSC - Prevention of Sepsis
2: WSC - Epidemiology and Long-Term Consequences of Sepsis
1: WSC - Evidence Based Sepsis Therapy
0: WSC - Introduction